Amgen bets on growth in China
U.S. biotech company Amgen is investing U.S. $2.7 billion in the Chinese firm Beigene.
Investing. Plain and simple.
U.S. biotech company Amgen is investing U.S. $2.7 billion in the Chinese firm Beigene.
An Indian doctor helped by a robot has performed heart procedures on patients miles away at another hospital.
As the healthcare sector expands its use of robots and AI, it is creating new investment opportunties.
The healthcare sector continues to expand its use of AI, robotics and the Internet of Things.
REITs are expanding beyond shopping centres and offices into the facilities that house cloud-based servers or enable biomedical research.
Microsoft has joined forces with a biotechnology firm to use AI software to help diagnose immune system diseases using a simple blood test.
The US Food and Drug Administration (FDA) is working with Merck, IBM, KPMG, and Walmart, in a pilot project aimedContinue Reading
Healthcare is in the spotlight as the U.S. presidential campaign gears up. Logistics giants FedEx and UPS stand to gain as the industry changes.
Medical device firms including Stryker Corp. and Johnson & Johnson are using 3D-printing to make surgical implants such as hip and knee joints.
Canada has very few home-grown heavyweights in the medical technology sector, so you have to look elsewhere for investment opportunities.









You must be logged in to post a comment.